Telos Capital Management, Inc. Novartis Ag Transaction History

Telos Capital Management, Inc.

$918 Million
Q4 2024

A detailed history of Telos Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Telos Capital Management, Inc. holds 27,686 shares of NVS stock, worth $2.92 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

27,686

Previous 26,647 3.9%

Holding current value

$2.92 Million

Previous $3.06 Million 12.08%

% of portfolio

0.29%

Previous 0.33%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	BUY	$96.78 - $117.18 $100,554 - $121,750	1,039 Added 3.9%	27,686 $2.69 Million
Q3 2024 Oct 21, 2024	SELL	$106.13 - $120.89 $45,635 - $51,982	-430 Reduced 1.59%	26,647 $3.06 Million
Q2 2024 Jul 31, 2024	BUY	$92.57 - $107.37 $60,355 - $70,005	652 Added 2.47%	27,077 $2.88 Million
Q1 2024 Apr 24, 2024	SELL	$95.27 - $108.47 $52,779 - $60,092	-554 Reduced 2.05%	26,425 $2.56 Million
Q4 2023 Jan 30, 2024	BUY	$92.27 - $101.54 $79,352 - $87,324	860 Added 3.29%	26,979 $2.72 Million
Q3 2023 Nov 01, 2023	SELL	$94.73 - $105.13 $43,102 - $47,834	-455 Reduced 1.71%	26,119 $2.66 Million
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $70,500 - $79,941	-762 Reduced 2.79%	26,574 $2.68 Million
Q1 2023 Apr 27, 2023	BUY	$80.03 - $92.81 $14,965 - $17,355	187 Added 0.69%	27,336 $2.51 Million
Q4 2022 Jan 27, 2023	BUY	$75.55 - $92.52 $204,967 - $251,006	2,713 Added 11.1%	27,149 $0
Q3 2022 Oct 31, 2022	BUY	$74.61 - $87.26 $91,770 - $107,329	1,230 Added 5.3%	24,436 $1.86 Million
Q2 2022 Aug 08, 2022	BUY	$80.52 - $93.75 $57,169 - $66,562	710 Added 3.16%	23,206 $1.96 Million
Q1 2022 May 02, 2022	SELL	$80.11 - $90.62 $17,624 - $19,936	-220 Reduced 0.97%	22,496 $1.97 Million
Q4 2021 Jan 21, 2022	BUY	$79.7 - $88.13 $15,382 - $17,009	193 Added 0.86%	22,716 $1.99 Million
Q3 2021 Oct 19, 2021	SELL	$81.78 - $95.14 $64,197 - $74,684	-785 Reduced 3.37%	22,523 $1.84 Million
Q2 2021 Jul 15, 2021	SELL	$85.24 - $94.15 $2.23 Million - $2.46 Million	-26,128 Reduced 52.85%	23,308 $2.13 Million
Q1 2021 Apr 28, 2021	BUY	$83.5 - $98.47 $36,072 - $42,539	432 Added 0.88%	49,436 $4.23 Million
Q4 2020 Feb 02, 2021	BUY	$78.07 - $94.43 $104,613 - $126,536	1,340 Added 2.81%	49,004 $4.63 Million
Q3 2020 Oct 27, 2020	BUY	$82.14 - $91.0 $75,075 - $83,174	914 Added 1.96%	47,664 $4.15 Million
Q2 2020 Jul 23, 2020	BUY	$80.93 - $91.1 $150,287 - $169,172	1,857 Added 4.14%	46,750 $4.08 Million
Q1 2020 May 01, 2020	BUY	$70.67 - $99.01 $41,412 - $58,019	586 Added 1.32%	44,893 $3.7 Million
Q4 2019 Jan 23, 2020	BUY	$84.35 - $95.37 $307,118 - $347,242	3,641 Added 8.95%	44,307 $4.2 Million
Q3 2019 Oct 31, 2019	BUY	$85.54 - $94.26 $80,749 - $88,981	944 Added 2.38%	40,666 $3.53 Million
Q2 2019 Jul 19, 2019	BUY	$75.4 - $92.8 $28,652 - $35,264	380 Added 0.97%	39,722 $3.63 Million
Q1 2019 Apr 18, 2019	BUY	$75.32 - $86.15 $39,919 - $45,659	530 Added 1.37%	39,342 $3.78 Million
Q4 2018 Jan 31, 2019	BUY	$73.66 - $82.02 $85,445 - $95,143	1,160 Added 3.08%	38,812 $3.33 Million
Q3 2018 Oct 26, 2018	BUY	$66.94 - $77.43 $34,942 - $40,418	522 Added 1.41%	37,652 $3.24 Million
Q2 2018 Jul 27, 2018	BUY	$64.91 - $73.36 $51,084 - $57,734	787 Added 2.17%	37,130 $2.81 Million
Q1 2018 Apr 24, 2018	BUY	$70.39 - $84.15 $21,468 - $25,665	305 Added 0.85%	36,343 $2.94 Million
Q4 2017 Jan 31, 2018	BUY	$72.33 - $77.64 $98,730 - $105,978	1,365 Added 3.94%	36,038 $3.03 Million
Q3 2017 Nov 03, 2017	BUY	$74.14 - $77.27 $2.57 Million - $2.68 Million	34,673	34,673 $2.98 Million

Others Institutions Holding NVS

# of Institutions

1,462

Shares Held

132M

Call Options Held

1.33M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Telos Capital Management, Inc. with notifications on news.

Account

Telos Capital Management, Inc. Novartis Ag Transaction History